Grey Matter Neurosciences

Technician performing an ultrasound exam
Grey Matter Neurosciences secures $14M for Alzheimer's Disease
By Anthony Vecchione | 02:56 pm | January 28, 2025
Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer's disease and test that device in clinical trials.